Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.43B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.38B |
| 3 |
Microsoft
MSFT
|
+$1.14B |
| 4 |
NVIDIA
NVDA
|
+$651M |
| 5 |
GE Aerospace
GE
|
+$553M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.55B |
| 2 |
Tesla
TSLA
|
+$1.36B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$723M |
| 4 |
Broadcom
AVGO
|
+$650M |
| 5 |
JPMorgan Chase
JPM
|
+$648M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 6.04% |
| 3 | Consumer Discretionary | 5.7% |
| 4 | Communication Services | 4.71% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
Sphere 3D
ANY
$18.7M
| $10.2K | ﹤0.01% |
+3,430
| New | +$20.5K |
|
4877
Savers
SVV
$1.66B
| $10.2K | ﹤0.01% |
1,090
-4,024
| -79% | -$41.4K |
|
4878
Kimbell Royalty Partners
KRP
$1.5B
| $10.2K | ﹤0.01% |
865
-4,501
| -84% | -$57.7K |
|
4879
OPAL Fuels
OPAL
$73.5M
| $10.1K | ﹤0.01% |
4,302
+2,783
| +183% | +$6.71K |
|
4880
Fresenius Medical Care
FMS
$12.6B
| $10.1K | ﹤0.01% |
423
-320
| -43% | -$7.96K |
|
4881
Similarweb
SMWB
$727M
| $9.99K | ﹤0.01% |
1,334
-972
| -42% | -$7.84K |
|
4882
Cerence
CRNC
$384M
| $9.93K | ﹤0.01% |
929
-5,285
| -85% | -$58.1K |
|
|
SLN
4883
Silence Therapeutics
SLN
$671M
| $9.86K | ﹤0.01% |
1,621
-152
| -9% | -$973 |
|
4884
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.09B
| $9.79K | ﹤0.01% |
201
+1
| +0.5% | +$48 |
|
|
STKL
4885
DELISTED
SunOpta
STKL
| $9.78K | ﹤0.01% |
2,563
-5,907
| -70% | -$26.8K |
|
4886
vTv Therapeutics
VTVT
$129M
| $9.76K | ﹤0.01% |
244
+243
| +24,300% | +$6.76K |
|
4887
PrimeEnergy Resources
PNRG
$310M
| $9.75K | ﹤0.01% |
57
-10
| -15% | -$1.61K |
|
4888
iBio
IBIO
$74.5M
| $9.74K | ﹤0.01% |
+5,046
| New | +$6.89K |
|
4889
Viemed Healthcare
VMD
$355M
| $9.73K | ﹤0.01% |
1,310
-1,774
| -58% | -$12.2K |
|
4890
Microbot Medical
MBOT
$116M
| $9.73K | ﹤0.01% |
+4,866
| New | +$11.5K |
|
4891
Ginkgo Bioworks
DNA
$498M
| $9.73K | ﹤0.01% |
1,171
-1,703
| -59% | -$18.3K |
|
4892
LivePerson
LPSN
$34.7M
| $9.72K | ﹤0.01% |
2,513
-127
| -5% | -$707 |
|
4893
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $9.7K | ﹤0.01% |
8
-6,483
| -100% | -$7.99M |
|
|
LBRX
4894
LB Pharmaceuticals
LBRX
$1.31B
| $9.68K | ﹤0.01% |
+435
| New | +$7.6K |
|
|
AGIG
4895
Abundia Global Impact Group
AGIG
$39.1M
| $9.66K | ﹤0.01% |
+4,880
| New | +$19.6K |
|
4896
Hyliion Holdings
HYLN
$720M
| $9.66K | ﹤0.01% |
5,250
+3,145
| +149% | +$6.33K |
|
4897
Sanara MedTech
SMTI
$315M
| $9.62K | ﹤0.01% |
412
+259
| +169% | +$6.69K |
|
4898
Global X SuperDividend ETF
SDIV
$1.21B
| $9.61K | ﹤0.01% |
400
| – | – |
|
4899
Alector
ALEC
$237M
| $9.6K | ﹤0.01% |
6,155
-47,783
| -89% | -$84.8K |
|
4900
FVCBankcorp
FVCB
$338M
| $9.6K | ﹤0.01% |
690
-792
| -53% | -$10.1K |
|
Similar funds
Citigroup's Q4 2025 Portfolio in Review
As of Q4 2025, Citigroup held 6,629 positions worth $227B, up 1% from $224B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q4 2025 filing shows 543 new, 2,396 increased, 2,457 reduced and 612 closed positions. Its largest new stake was MicroSectors Gold Miners 3x Leveraged ETN: 123,671 shares worth $30.1M. The largest sale was Bank of America, an estimated $1.55B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
- Citigroup's largest Q4 2025 buy was MicroSectors Gold Miners 3x Leveraged ETN: 123,671 shares worth $30.1M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $3.43B increase.
- Citigroup's biggest Q4 2025 reduction was Bank of America, cutting an estimated $1.55B.
- Citigroup fully exited Mr. Cooper in Q4 2025, selling an estimated $175M.
- Citigroup's ten largest holdings make up 20% of its $227B portfolio in Q4 2025.
- Citigroup opened 543 new positions and closed 612 in Q4 2025.
- Citigroup's portfolio value rose 1% quarter-over-quarter to $227B.
Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.